Optical imaging firm submits application
Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser
Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser Mammography (CTLM), is designed as an adjunct to x-ray mammography for women who have dense breasts and equivocal mammograms, adding information to guide biopsy recommendations. Clinical studies of the technology began six years ago (SCAN 2/19/97).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
